New research brings stem cells one step closer to clinical use.
Security concerns are already surfacing.
A startup focusing on cheap, dispensable tests wins MIT prize.
Research team led by MIT professor.
It could be a boon to genomics research and personal genomics companies.
Empowering students to improve a billion lives.
Regulators debate what kinds of tests are needed to begin.
The company is using its supercomputing prowess to augment experiments at the University of Edinburgh investigating the HIV infection process.
The controversial approach could help overcome a major hurdle in stem cell research.
The findings highlight the role that rare duplications and deletions play in disease.